Augmentation of IL-6 production contributes to development of gestational diabetes mellitus: An Indian study

Diabetes Metab Syndr. 2019 Mar-Apr;13(2):895-899. doi: 10.1016/j.dsx.2018.12.023. Epub 2018 Dec 27.

Abstract

Aim: Inflammatory mediators like interleukin-6 (IL-6) and acute phase protein like C-reactive protein (CRP) are supposed to contribute to development of GDM, however clinical data supporting this hypothesis is limited. This study was designed to analyze the association of IL-6 and CRP with development of GDM in Indian females.

Methods: This case control study included pregnant women diagnosed as GDM (n = 53) and those having normal glucose tolerance (n = 50). Serum levels of IL-6 and CRP were analysed and correlated with various clinical parameters.

Results: Serum IL-6 levels were significantly high (p < 0.05) in GDM females as compared to control females. IL-6 levels correlated with pre-pregnancy body mass index (BMI), fasting blood sugar (FBS) and postprandial sugar (PPBS). Unlike IL-6, CRP levels did not show significant differences between GDM and control females. However, positive correlation of CRP levels with BMI, FBS and PPBS was observed.

Conclusion: High IL-6 levels in gestational diabetes may indicate a possible role for inflammation in pathophysiology of GDM.

Keywords: CRP; Gestational diabetes mellitus; IL-6; Inflammation.

MeSH terms

  • Adult
  • Biomarkers / blood*
  • C-Reactive Protein / analysis*
  • Case-Control Studies
  • Diabetes, Gestational / blood*
  • Diabetes, Gestational / epidemiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • India / epidemiology
  • Interleukin-6 / blood*
  • Pregnancy
  • Prognosis

Substances

  • Biomarkers
  • IL6 protein, human
  • Interleukin-6
  • C-Reactive Protein